RxDoctor Payments Data

James Chang, MD

Vascular Surgery · Atlanta, GANPI 1962846873

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.6%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Penumbra, Inc. at 40.4% of the total. 2025 is the largest year on record at $8,700, 2.6 times the $3,317 reported in 2019. Among vascular surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,825in general payments, 2019–2025

Across 168 payments — averaging $183.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$12K
  • Bolton Medical Inc$5K
  • W. L. Gore & Associates, Inc.$4K
  • Artivion, Inc.$3K
  • Medtronic$2K
  • Silk Road Medical, Inc.$1K
  • plus $3K from 12 others

What the payments were for

  • Speaking & faculty fees$7,30024%
  • Grants$9503%
  • Travel & lodging$12,19340%
  • Food & beverage$10,29433%
  • Education$880%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,825 in reported general payments places this provider in the 90th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$282,770
Medicare patients
1,249
Services billed
2,562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban100$65,913
XareltoRivaroxaban52$37,939
ClopidogrelClopidogrel Bisulfate256$2,396
Cilostazol58$877
Rosuvastatin Calcium81$843
Gabapentin26$428
Atorvastatin Calcium48$347
Pentoxifylline12$171
Tramadol Hcl36$73
Oxycodone Hcl13$39
Alprazolam11$5

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →